Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.
Lau E, McCoy P, Reeves F, Chow K, Clarkson M, Kwan EM, Packwood K, Northen H, He M, Kingsbury Z, Mangiola S, Kerger M, Furrer MA, Crowe H, Costello AJ, McBride DJ, Ross MT, Pope B, Hovens CM, Corcoran NM.
Lau E, et al. Among authors: hovens cm.
Genome Med. 2020 Aug 17;12(1):72. doi: 10.1186/s13073-020-00770-1.
Genome Med. 2020.
PMID: 32807235
Free PMC article.